Medicare Part D 2016 Formulary Changes Service To Senior and OC Preferred
|
|
|
- Julius Shields
- 5 years ago
- Views:
Transcription
1 Medicare Part D 2016 Formulary s Service To Senior and OC Preferred Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior authorization, quantity limits and/or step therapy restrictions or move a drug to a higher cost-sharing tier, we will notify you of the change at least 60 days before the date that the change becomes effective. However, if the U.S. Food and Drug Administration (FDA) determines a drug on our formulary to be unsafe or the drug s manufacturer removes the drug from the market, we will immediately remove the drug from our formulary. The table below outlines changes made to our formulary throughout VERSION: FORMULARY ADDITIONS UPDATE AS OF MAY 1, 2016: FORMULARY ID: Formulary additions, reductions in preferred or tiered cost-sharing status, or removal of to an existing formulary drug Covered Drug Name ANDROGEL GEL PUMP 1% TESTOSTERONE DELETION 05/01/16 4 QL (300 PER 30 DAYS) BIVIGAM INJ 10% IMMUNE GLOBULIN ADDITION 05/01/16 5 FLEBOGAMMA INJ DIF 10% IMMUNE GLOBULIN ADDITION 05/01/16 5 FLUCONAZOLE/ INJ DEX 400 FLUCONAZOLE/ INJ DEX ADDITION 05/01/16 2 FLUCONAZOLE/ INJ DEX 400 FLUCONAZOLE/ INJ DEX DELETION 05/01/16 2 GAMMAKED INJ 1GM/10ML IMMUNE GLOBULIN ADDITION 05/01/16 5 1
2 GAMMAPLEX INJ 10GM IMMUNE GLOBULIN ADDITION 05/01/16 5 IMATINIB MES TAB 100MG GLEEVEC ADDITION 05/01/16 2 QL (90 PER 30 DAYS) IMATINIB MES TAB 400MG GLEEVEC ADDITION 05/01/16 2 QL (60 PER 30 DAYS) MOLINDONE TAB HCL 10MG MOLINDONE UPDATE 05/01/16 2 MOLINDONE TAB HCL 25MG MOLINDONE UPDATE 05/01/16 2 MOLINDONE TAB HCL 5MG MOLINDONE UPDATE 05/01/16 2 OCTAGAM INJ 25GM IMMUNE GLOBULIN ADDITION 05/01/16 5 OCTAGAM INJ 2GM/20ML IMMUNE GLOBULIN ADDITION 05/01/16 5 OLOPATADINE DRO 0.1% PATANOL ADDITION 05/01/16 2 PRIVIGEN INJ 20GRAMS IMMUNE GLOBULIN ADDITION 05/01/16 5 SUPREP BOWEL SOL PREP SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE ADDITION 05/01/16 3 VRAYLAR CAP 1.5MG CARIPRAZINE ADDITION 05/01/16 4 VRAYLAR CAP 3MG CARIPRAZINE ADDITION 05/01/16 4 VRAYLAR CAP 4.5MG CARIPRAZINE ADDITION 05/01/16 4 VRAYLAR CAP 6MG CARIPRAZINE ADDITION 05/01/16 4 AVANDIA TAB 8MG ROSIGLITAZONE DELETION 4/1/ QL (60 PER 30 DAYS) EMPLICITI INJ 400MG ADDITION 5 ELOTUZUMAB 4/1/2016 GLEOSTINE CAP 100MG LOMUSTINE ADDITION 4/1/ GLEOSTINE CAP 10MG LOMUSTINE ADDITION 4/1/ GLEOSTINE CAP 40MG LOMUSTINE ADDITION 4/1/
3 INVEGA TRINZ INJ 273MG ADDITION 5 PALIPERIDONE 4/1/2016 INVEGA TRINZ INJ 410MG ADDITION 5 PALIPERIDONE 4/1/2016 INVEGA TRINZ INJ 546MG ADDITION 5 PALIPERIDONE 4/1/2016 INVEGA TRINZ INJ 819MG ADDITION 5 PALIPERIDONE 4/1/2016 LOMUSTINE CAP 100MG LOMUSTINE DELETION 4/1/ LOMUSTINE CAP 10MG LOMUSTINE DELETION 4/1/ LOMUSTINE CAP 40MG LOMUSTINE DELETION 4/1/ PHENYTOIN EX CAP 200MG DILANTIN ADDITION 4/1/ PHENYTOIN EX CAP 300MG DILANTIN ADDITION 4/1/ TRIAMCINOLON SPR DELETION 55MCG/AC NASACORT 4/1/ QL (33 PER 30 DAYS) VIIBRYD KIT STARTER VILAZODONE ADDITION 4/1/ ABILIFY DISC TAB 10MG ARIPIPRAZOLE DELETION 3/1/ ALECENSA CAP 150MG ALECTINIB ADDITION 3/1/ ALOSETRON TAB 0.5MG LOTRONEX ADDITION 3/1/ ALOSETRON TAB 1MG LOTRONEX ADDITION 3/1/2016 2, QL (90 PER 30 DAYS), QL (60 PER 30 DAYS), QL (60 PER 30 DAYS) 3
4 ARIPIPRAZOLE TAB 10MG ABILIFY ADDITION 3/1/2016 2, QL (90 PER 30 DAYS) AVASTIN INJ 400/16ML BEVACIZUMAB ADDITION 3/1/ BEXAROTENE CAP 75MG TARGRETIN ADDITION 3/1/ BREO ELLIPTA INH FLUTICASONE AND VILANTEROL ADDITION 3/1/ CLOZAPINE TAB 100/ODT FAZACLO ADDITION 3/1/ QL (270 PER 30 DAYS) CLOZAPINE TAB 12.5/ODT FAZACLO ADDITION 3/1/ QL (90 PER 30 DAYS) CLOZAPINE TAB 150/ODT FAZACLO ADDITION 3/1/ QL (180 PER 30 DAYS) CLOZAPINE TAB 200/ODT FAZACLO ADDITION 3/1/ QL (120 PER 30 DAYS) CLOZAPINE TAB 25MG ODT FAZACLO ADDITION 3/1/ QL (270 PER 30 DAYS) COTELLIC TAB 20MG COBIMETINIB ADDITION 3/1/ CYRAMZA INJ 100/10ML RAMUCIRUMAB ADDITION 3/1/ CYRAMZA INJ 500/50ML RAMUCIRUMAB ADDITION 3/1/ DARZALEX SOL 100MG/5M DARATUMUMAB ADDITION 3/1/ DUTASTERIDE CAP 0.5MG AVODART ADDITION 3/1/ QL (30 PER 30 DAYS) EMPLICITI INJ 300MG ELOTUZUMAB ADDITION 3/1/ ENVARSUS XR TAB 0.75MG TACROLIMUS EXTENDED- RELEASE TABLETS ADDITION 3/1/
5 ENVARSUS XR TAB 1MG TACROLIMUS EXTENDED- RELEASE TABLETS ADDITION 3/1/ ENVARSUS XR TAB 4MG TACROLIMUS EXTENDED- RELEASE TABLETS ADDITION 3/1/ FLUTICASONE SPR 50MCG FLONASE UPDATED 3/1/ QL (16 PER 25 DAYS) FOSCARNET INJ 24MG/ML FOSCARNET DELETION 3/1/ GENVOYA TAB ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE ADDITION 3/1/ GLATOPA INJ 20MG/ML GLATIRAMER ACETATE ADDITION 3/1/2016 2, QL (30 PER 30 DAYS) GLEOSTINE CAP 5MG LOMUSTINE ADDITION 3/1/ IRESSA TAB 250MG GEFITINIB ADDITION 3/1/ KEYTRUDA INJ 100MG/4M PEMBROLIZUMAB ADDITION 3/1/ KLOR-CON 10 TAB 10MEQ ER POTASSIUM CHLORIDE 3/1/ KLOR-CON 8 TAB 8MEQ ER POTASSIUM CHLORIDE 3/1/ LANTUS INJ 100/ML INSULIN GLARGINE 3/1/ QL (30 PER 30 DAYS) LEVOTHYROXIN TAB 100MCG 3/1/
6 LEVOTHYROXIN TAB 112MCG LEVOTHYROXIN TAB 125MCG LEVOTHYROXIN TAB 137MCG LEVOTHYROXIN TAB 150MCG LEVOTHYROXIN TAB 175MCG LEVOTHYROXIN TAB 200MCG LEVOTHYROXIN TAB 25MCG LEVOTHYROXIN TAB 300MCG LEVOTHYROXIN TAB 50MCG LEVOTHYROXIN TAB 75MCG LEVOTHYROXIN TAB 88MCG LONSURF TAB LONSURF TAB LYRICA CAP 100MG 3/1/ /1/ /1/ /1/ /1/ /1/ /1/ /1/ /1/ /1/ /1/ TRIFLURIDINE AND TIPIRACIL ADDITION 3/1/ TRIFLURIDINE AND TIPIRACIL ADDITION 3/1/ /1/
7 LYRICA CAP 150MG 3/1/ LYRICA CAP 200MG 3/1/ LYRICA CAP 225MG 3/1/ LYRICA CAP 25MG 3/1/ LYRICA CAP 300MG 3/1/ LYRICA CAP 50MG 3/1/ LYRICA CAP 75MG 3/1/ LYRICA SOL 20MG/ML 3/1/ MEMANT TITRA PAK 5-10MG NAMENDA ADDITION 3/1/ QL (60 PER 30 DAYS) MEMANTINE TAB HCL 10MG NAMENDA ADDITION 3/1/ QL (60 PER 30 DAYS) MEMANTINE TAB HCL 5MG NAMENDA ADDITION 3/1/ QL (60 PER 30 DAYS) MOLINDONE TAB HCL 10MG MOLINDONE ADDITION 3/1/ MOLINDONE TAB HCL 25MG MOLINDONE ADDITION 3/1/ MOLINDONE TAB HCL 5MG MOLINDONE ADDITION 3/1/ MYCOPHENOLAT CAP 250MG CELLCEPT 3/1/ MYCOPHENOLAT SUS 200MG/ML CELLCEPT 3/1/
8 MYCOPHENOLAT TAB 500MG CELLCEPT 3/1/2016 2, QL (21 PER 21 DAYS) NEUMEGA INJ 5MG OPRELVEKIN DELETION 3/1/ NEVIRAPINE TAB 100MG VIRAMUNE XR ADDITION 3/1/ NINLARO CAP 2.3MG IXAZOMIB ADDITION 3/1/ NINLARO CAP 3MG IXAZOMIB ADDITION 3/1/ NINLARO CAP 4MG IXAZOMIB ADDITION 3/1/ ODOMZO CAP 200MG SONIDEGIB ADDITION 3/1/ OLOPATADINE SPR 0.6% PATANASE ADDITION 3/1/ PALIPERIDONE TAB ER 1.5MG INVEGA ADDITION 3/1/ QL (240 PER 30 DAYS) PALIPERIDONE TAB ER 3MG INVEGA ADDITION 3/1/ QL (120 PER 30 DAYS) PALIPERIDONE TAB ER 6MG INVEGA ADDITION 3/1/ QL (60 PER 30 DAYS) PALIPERIDONE TAB ER 9MG INVEGA ADDITION 3/1/ QL (60 PER 30 DAYS) PHENYTOIN EX CAP 200MG DILANTIN DELETION 3/1/ PHENYTOIN EX CAP 300MG DILANTIN DELETION 3/1/ PIMOZIDE TAB 1MG ORAP ADDITION 3/1/ PIMOZIDE TAB 2MG ORAP ADDITION 3/1/ POT CHLORIDE CAP 10MEQ ER POTASSIUM CHLORIDE 3/1/ POT CHLORIDE CAP 8MEQ ER POTASSIUM CHLORIDE 3/1/ POT CHLORIDE LIQ 10% POTASSIUM CHLORIDE 3/1/
9 POT CHLORIDE LIQ 20% POTASSIUM CHLORIDE 3/1/ PREDNISOLONE SUS 1% OP PRED FORTE 3/1/ PREMARIN TAB 0.3MG CONJUGATED ESTROGENS ADDITION 3/1/ PREMARIN TAB 0.45MG CONJUGATED ESTROGENS ADDITION 3/1/ PREMARIN TAB 0.9MG CONJUGATED ESTROGENS ADDITION 3/1/ PREMARIN TAB 1.25MG CONJUGATED ESTROGENS ADDITION 3/1/ REXULTI TAB 0.25MG BREXPIPRAZOLE ADDITION 3/1/ QL (480 PER 30 DAYS) REXULTI TAB 0.5MG BREXPIPRAZOLE ADDITION 3/1/ QL (240 PER 30 DAYS) REXULTI TAB 1MG BREXPIPRAZOLE ADDITION 3/1/ QL (120 PER 30 DAYS) REXULTI TAB 2MG BREXPIPRAZOLE ADDITION 3/1/ QL (60 PER 30 DAYS) REXULTI TAB 3MG BREXPIPRAZOLE ADDITION 3/1/ QL (30 PER 30 DAYS) REXULTI TAB 4MG BREXPIPRAZOLE ADDITION 3/1/ QL (30 PER 30 DAYS) RIVASTIGMINE DIS 13.3/24 EXELON ADDITION 3/1/ RIVASTIGMINE DIS 4.6MG/24 EXELON ADDITION 3/1/ RIVASTIGMINE DIS 9.5MG/24 EXELON ADDITION 3/1/ TAGRISSO TAB 40MG OSIMERTINIB ADDITION 3/1/ TAGRISSO TAB 80MG OSIMERTINIB ADDITION 3/1/ TANZEUM INJ 30MG ALBIGLUTIDE ADDITION 3/1/ TANZEUM INJ 50MG ALBIGLUTIDE ADDITION 3/1/ TESTOSTERONE GEL 1%(25MG) ANDROGEL ADDITION 3/1/ QL (300 PER 30 DAYS) TESTOSTERONE GEL 1%(50MG) ANDROGEL ADDITION 3/1/ QL (300 PER 30 DAYS) 9
10 TETRABENAZIN TAB 12.5MG XENAZINE ADDITION 3/1/ TETRABENAZIN TAB 25MG XENAZINE ADDITION 3/1/ THIOTEPA INJ 15MG THIOTEPA ADDITION 3/1/ XELJANZ TAB 5MG TOFACITINIB ADDITION 3/1/ ALOSETRON TAB 0.5MG LOTRONEX ADDITION 1/1/ ALOSETRON TAB 1MG LOTRONEX ADDITION 1/1/ BEXAROTENE TARGRETIN ADDITION 1/1/ GLATOPA INJ 20MG/ML COPAXONE ADDITION 1/1/ LANTUS INJ 100/ML VIAL LEVOTHYROXINE TAB 25MCG LEVOTHYROXINE TAB 50MCG LEVOTHYROXINE TAB 75MCG LEVOTHYROXINE TAB 88MCG INSULIN GLARGINE LEVOTHYROXINE LEVOTHYROXINE LEVOTHYROXINE LEVOTHYROXINE, QL(60 per 30 days), QL(60 per 30 days) QL(30 per 30 days), 1/1/ QL (30 per 30 days) 10
11 LEVOTHYROXINE TAB 100MCG LEVOTHYROXINE LEVOTHYROXINE TAB 112MCG LEVOTHYROXINE LEVOTHYROXINE TAB 125MCG LEVOTHYROXINE LEVOTHYROXINE TAB 137MCG LEVOTHYROXINE LEVOTHYROXINE TAB 150MCG LEVOTHYROXINE LEVOTHYROXINE TAB 175MCG LEVOTHYROXINE LEVOTHYROXINE TAB 200MCG LEVOTHYROXINE LEVOTHYROXINE TAB 300MCG LEVOTHYROXINE KLOR-CON 8 TAB 8MEQ ER POTASSIUM CHLORIDE KLOR-CON 10 TAB 10MEQ ER POTASSIUM CHLORIDE KLOR-CON M20 TAB 20MEQ ER POTASSIUM CHLORIDE LYRICA CAP 25MG LYRICA CAP 50MG LYRICA CAP 75MG 1/1/ /1/ /1/
12 LYRICA CAP 100MG 1/1/ LYRICA CAP 225MG 1/1/ LYRICA CAP 300MG 1/1/ LYRICA SOL 20MG/ML 1/1/ MEMANTINE TAB HCL 5MG NAMENDA ADDITION 1/1/ QL (60 per 30 days) MEMANTINE TAB HCL 10MG NAMENDA ADDITION 1/1/ QL (60 per 30 days) MEMANTINE TITRA PAK 5-10MG NAMENDA ADDITION 1/1/ QL (60 per 30 days) PREMARIN TAB 0.3MG CONJUGATED ESTROGENS ADDITION 1/1/ PREMARIN TAB 0.45MG CONJUGATED ESTROGENS ADDITION 1/1/ PREMARIN TAB 0.9MG CONJUGATED ESTROGENS ADDITION 1/1/ PREMARIN TAB 1.25MG CONJUGATED ESTROGENS ADDITION 1/1/ XELJANZ TAB 5MG TOFACITINIB ADDITION 1/1/
13 13
14 14
15 15
Medicare Part D 2016 Formulary Changes Service To Senior and OC Preferred
Medicare Part D 2016 Formulary s Service To Senior and OC Preferred Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior
Medicare Part D 2016 Formulary Changes Desert Preferred Choice
Medicare Part D 2016 Formulary s Desert Preferred Choice Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior authorization,
Aetna Better Health Illinois Premier Plan. November 2015 Formulary Updates. October 2015 Formulary Updates
Aetna Better Health Illinois Premier Plan November 2015 Formulary Updates desogestrel & ethinyl estradiol tab 0.15 mg-30 mcg RIVASTIGMINE DIS 13.3/24; QL (30 patches/30 days) RIVASTIGMINE DIS 4.6MG/24;
Aetna Better Health FIDA Plan
Aetna Better Health FIDA Plan May 2016 Formulary Updates ASCOMP/COD - QL; PA FYAVOLV 5MCG; 1MG- PA METOPROLOL TABS 37.5MG, 75MG CIPRODEX LETAIRIS - QL; PA OFEV - QL; PA OTREXUP - ST PRALUENT - QL; PA RASUVO
Formulary Change Notice
Formulary Change Notice HealthPartners may remove drugs from our formulary (list of covered drugs) or add rules about whether and when certain drugs are covered during the year. The chart below contains
Medicare Part D 2012 Formulary Changes Service To Senior and Total Fit
Medicare Part D 2012 Formulary s Service To Senior and Total Fit Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior authorization,
2016 Medicare Part D Formulary Change
2016 Medicare Part D Formulary Change We may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, or add prior authorizations, quantity limits and/or step therapy
Network Health Insurance Corporation Upcoming Negative Changes to the Medicare Part D Formulary
Requesting an Exception to the Formulary You can ask Network Health Insurance Corporation to make an exception to our coverage rules. Generally, we will only approve your request for an exception if alternative
August 2016 Formulary Updates
August 2016 Formulary Updates DOXYCYCLINE HYCLATE TABS DR 50MG, 200MG NALOXONE HCL INJ 0.4MG/ML VANCOMYCIN HCL INJ 500MG, 750MG BRIVIACT INJ - PA BRIVIACT ORAL SOLN - QL; PA BRIVIACT TABS - QL; PA LENVIMA
You can win a Pizza Party for your office!
You can win a Pizza Party for your office! Geeta Patwa, MD and her staff from Chaparral Medical Group were the winners of the last InfoLink Pizza Party. IMPROVING QUALITY OF LIFE: INTER VALLEY FOCUSES
Medicare Part D 2017 Formulary Changes Service To Senior
Medicare Part D 2017 Formulary s Service To Senior Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior authorization,
Medicare Part D 2017 Formulary Changes OC Preferred
Medicare Part D 2017 Formulary Changes OC Preferred Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior authorization,
Medicare Part D 2017 Formulary Changes OC Preferred
Medicare Part D 2017 Formulary s OC Preferred Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior authorization, quantity
New Generics: Specialty Network: Retail Pharmacies Dispensing Specialty Products
SUPPORTING OUR PROVIDER PARTNERS THROUGH COMMUNICATION AND COLLABORATION. DATE JANUARY 2016 ISSUE 1 HELPFUL NUMBERS FOR PROVIDERS Magellan: 1-800-846-7971 Bin: 016523 Processor control: 747 HELPFUL NUMBERS
2016 FORMULARY ADDENDUM NOTICE OF CHANGE
2016 FORMULARY ADDENDUM NOTICE OF CHANGE (PRESCRIPTION DRUG PLANS) WELLCARE PRESCRIPTION INSURANCE, INC. WellCare Simple (PDP) WellCare Classic (PDP) WellCare Extra (PDP) This is a listing of the changes
ALLERGIC CONJUNCTIVITIS AGENTS
2018 5 Tier Standard- Keystone First VIP Choice Document: 2018 Step Therapy Formulary ID: 18390 Last Updated: 04/2018 Effective Date: 05-01-2018 ALLERGIC CONJUNCTIVITIS AGENTS epinastine 0.05 % eye drops
Medicare Part D 2017 Formulary Changes OC Preferred
Medicare Part D 017 Formulary s OC Preferred Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior authorization, quantity
December 2016 Formulary Updates
December 2016 Formulary Updates ABACAVIR/LAMIVUDINE AMLODIPINE/OLMESARTAN MEDOXOMIL TAB 10-20MG QL AMLODIPINE/OLMESARTAN MEDOXOMIL TAB 10-40MG QL AMLODIPINE/OLMESARTAN MEDOXOMIL TAB 5-20MG QL AMLODIPINE/OLMESARTAN
Health Partners Medicare Prime 2019 Formulary Changes
Health Partners Medicare Prime 2019 Formulary Changes Changes occur, for example, because new drugs come on the market, a drug is moved to a different cost-sharing level (tier), or a generic version becomes
Medicare Part D 2015 Formulary Changes Desert Preferred Choice
Medicare Part D 2015 Formulary s Desert Preferred Choice Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior authorization,
November 2016 Formulary Updates
November 2016 Formulary Updates DAPTOMYCIN LARISSIA NITROGLYCERIN SUBL ORFADIN 20MG CAP PA RELISTOR 150MG TAB PA; QL Over-the-Counter (OTC) Drugs Added* COLEMAN SKINSMART INSECT REP CUTTER BACKWOODS AERO
Quarterly pharmacy formulary change notice
Quarterly pharmacy formulary change notice Summary of change: The Pharmacy and Therapeutics Committee (P&T) reviewed and approved the formulary changes listed in the table below on March 29, 2016. What
2017 Step Therapy Criteria
FRESENIUS TOTAL HEALTH 2017 Step Therapy Updated 07/01/2017. For more recent information or other questions, please contact Fresenius Total Health Customer Service at 1-855-598-6774 / TTY 1-844-209-9094.
2018 Formulary Notice of Change Prescription Drug Plans
2018 Formulary Notice of Change Prescription Drug Plans WellCare Prescription Insurance, Inc. Plans in all states: WellCare Classic (PDP) WellCare may add or remove drugs from our formulary during the
December 2016 Formulary Updates
December 2016 Formulary Updates ABACAVIR/LAMIVUDINE AMLODIPINE/OLMESARTAN MEDOXOMIL TAB 10-20MG QL AMLODIPINE/OLMESARTAN MEDOXOMIL TAB 10-40MG QL AMLODIPINE/OLMESARTAN MEDOXOMIL TAB 5-20MG QL AMLODIPINE/OLMESARTAN
ANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY
South Country Health Alliance 2017 Step Therapy Formulary ID: 17431 Last Updated: 10/20/2017 Effective Date: 11-01-2017 ANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY BENICAR 20 MG BENICAR 40 MG BENICAR 5
Changes to the 2018 BlueCross Secure SM (HMO) & BlueCross Total SM (PPO) Formularies
Changes to the 2018 BlueCross Secure SM (HMO) & BlueCross Total SM (PPO) Formularies BlueCross BlueShield of South Carolina may add or remove drugs from the formulary during the year. If we remove drugs
Memorial Hermann Advantage HMO February 2019 Formulary Addendum
Memorial Hermann Advantage HMO February 2019 Formulary Addendum Changes may have occurred since the printing of your current Memorial Hermann Advantage HMO Formulary. Medications that may have been added
ate Formulary Upda ). We are open: October 1 February 8 a.m. 8 a.m. February drugs: You ask us to pay Formulary attached If you
MEDICARE ADVANTAGE HealthNow New York Formulary Upda ate Please note, the HealthNow New York Formulary has been updated since its original printing in September, 2015. This insert outlines all of the updates
Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates
Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates July 2018 TRADE NAME (generic name) or generic name ADVAIR DISKUS (fluticasone-salmeterol aer powder ba 100-50 mcg/dose) Brand Addition ADVAIR
PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select Formulary April 1, 2018 Updates. Formulary Alternatives
PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select April 1, 2018 Updates Drug Name adapalene-benzoyl-peroxide Gel 0.1-2.5% (Brand = Epiduo ) prasugrel hcl (Brand = Effient ) vigabatrin pak 500 mg (Brand
Aetna Better Health of Illinois Medicaid Formulary Updates
October 2017 o DOXYLAMINE SUCCINATE 25mg-QL o DULOXETINE CAP 40MG DR-QL o GUANFACIN ER TABS (all strengths)-ql o TOBRAMYCIN NEBU SOLUTION- PA August 2017 Aetna Better Health of Illinois Medicaid 2017 Formulary
SecureBlue Formulary 2016 Master Negative Changes from 2015 to 2016
Beta-lactam, SUPRAX TAB 400MG Suprax 400 mg cap Antibacterials Cephalosporins Beta-lactam, CEFOTAXIME INJ 10GM cefotaxime 2 gm inj Antibacterials Cephalosporins ERYTHROCIN INJ 1000MG Erythrocin 500 mg
PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select Formulary April 1, 2018 Updates. Formulary Alternatives
PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select April 1, 2018 Updates Drug Name adapalene-benzoyl-peroxide Gel 0.1-2.5% (Brand = Epiduo ) prasugrel hcl (Brand = Effient ) vigabatrin pak 500 mg (Brand
Drugs requiring prior authorization: the list of drugs requiring prior authorization for this clinical criteria
Drug/Drug Class Antipsychotics Clinical Criteria Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization for this clinical criteria Prior
Antipsychotics Prior Authorization Criteria for Louisiana Fee for Service and MCO Medicaid Recipients
Antipsychotics Prior Authorization Criteria for Louisiana Fee for Service and MCO Medicaid Recipients Preferred Agents (Oral) a Amitriptyline/Perphenazine (Generic) Aripiprazole Tablet (Generic) b Chlorpromazine
Quarterly pharmacy formulary change notice
Provider Bulletin June 24, 2016 Summary of change The Pharmacy and Therapeutics Committee reviewed and approved the formulary changes listed in the table below on March 29, 2016. What this means to you
Pharmacy Medical Necessity Guidelines: Antipsychotic Medications
Pharmacy Medical Necessity Guidelines: Effective: October 1, 2016 Prior Authorization Required Type of Review Care Management Not Covered Type of Review Clinical Review Pharmacy (RX) or Medical (MED) Benefit
Pharmacy and Therapeutics (P&T) Committee Provider Update
Pharmacy and Therapeutics (P&T) Committee Provider Update THIRD QUARTER 2018 P&T Committee Decisions Effective September 1, 2018 Dear Healthcare Practitioner: The Presbyterian Health Plan, Inc., and Presbyterian
Pharmacy Medical Necessity Guidelines: Antipsychotic Medications
Pharmacy Medical Necessity Guidelines: Effective: April 1, 2018 Prior Authorization Required Type of Review Care Management Not Covered Type of Review Clinical Review Pharmacy (RX) or Medical (MED) Benefit
Clinical Therapeutic Intelligence Report: 2015 Year in Review
Clinical Therapeutic Intelligence Report: 2015 Year in Review This issue highlights the many ground-breaking therapies approved by the U.S. Food and Drug Administration over the course of 2015. Highlights
Notice of Mid-Year Changes to 2019 Paramount Enhanced Formulary
Notice of Mid-Year s to 2019 Paramount Enhanced Formulary Paramount Elite (HMO) may immediately remove a brand name drug on our List if we are replacing it with a new generic drug that will appear on the
2018 Drug List Negative Changes Updated 10/25/2018 The table below shows changes made to our 2018 List of Covered Drugs (Formulary).
2018 Drug List Negative s Updated 10/25/2018 The table below shows changes made to our 2018 List of Covered Drugs (Formulary). Date of 1/1/2018 COLYTE-FLAVOR PACKS SOLR 227.1GM- 21.5GM-5.53GM- 2.82GM-6.36GM
Pharmacy Benefit Management (PBM) Program FORMULARY/PRODUCT RESTRICTIONS
Workforce Safety & Insurance Revised Document Date: 07/21/2015 1600 E Century Ave Ste 1 PO Box 5585 Bismarck, ND 58506-5585 701.328.3800 1.800.777.5033 www.workforcesafety.com Pharmacy Benefit Management
Superior Select Health Plans: Tribute-1 Tier May 2018 Formulary Addendum
Superior Select Health Plans: Tribute-1 Tier May 2018 Formulary Addendum Below is a list formulary changes for the benefit year 2018. This is not a complete list of drugs covered by the Part D plan. The
TEST ANTICONVULSANT THERAPY. Products Affected. Step 2: Network Health Insurance Corporation NetworkCares Step Therapy Criteria Last Updated 11/2018
TEST Network Health Insurance Corporation NetworkCares Step Therapy Last Updated 11/2018 ANTICONVULSANT THERAPY Aptiom Banzel Briviact Celontin Dilantin 30 Mg Capsule Equetro Fycompa 0.5 Mg/ml Oral Susp
Medicare Part D 2017 Formulary Changes Service To Senior
Medicare Part D 2017 Formulary Changes Service To Senior Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior authorization,
Step Therapy Group. Atypical Antipsychotic Agents
Atypical Antipsychotic Agents Any beneficiary newly enrolled into Community Care, Inc. currently receiving aripiprazole, aripiprazole ODT, risperidone, risperidone ODT, olanzapine, olanzapine ODT, quetiapine,
Granite Alliance Insurance Company (PDP) 2018 Step Therapy Criteria Last Updated: 10/23/18
Granite Alliance Insurance Company (PDP) 2018 Step Therapy Criteria Last Updated: 10/23/18 Granite Alliance requires step therapy for certain drugs. This means prior to receiving a drug with a step therapy
WellCare s South Carolina Preferred Drug List Update
WellCare s South Carolina Preferred Drug List Update This is a list of changes to our preferred drug list. These are a result of the latest WellCare Pharmacy & Therapeutics meeting held on 09/21/2017.
2014 Quantity Limits (QL) Criteria
2014 Quantity Limits (QL) Criteria Certain drugs covered through your EmblemHealth Medicare HMO/PPO Medicare Plan are covered for only a limited quantity. We do this to ensure compliance with the US Food
2018 CareOregon Advantage Part D Formulary Changes
2018 CareOregon Advantage Part D Formulary Changes Abbreviations: AGE = Age Restriction; PA = Prior Authorization Required; QL = Quantity Limit; ST = Step Therapy Required; LD = Limited Distribution; BvD
Antipsychotic Medications Age and Step Therapy
Market DC *- Florida Healthy Kids Antipsychotic Medications Age and Step Therapy Override(s) Approval Duration Prior Authorization 1 year Quantity Limit *Virginia Medicaid See State Specific Mandates *Indiana
ANTICONVULSANTS. Details. Step Therapy Criteria Date Effective: April 1, 2019
Step Therapy Date Effective: April 1, 2019 ANTICONVULSANTS APTIOM TABLET 200 MG ORAL APTIOM TABLET 400 MG ORAL APTIOM TABLET 600 MG ORAL APTIOM TABLET 800 MG ORAL BANZEL SUSPENSION 40 MG/ML ORAL BANZEL
VIVA MEDICARE IMPORTANT T EXPANDED PERFORMANCE FORMULARY UPDATES
NORE/ETH/FER CHW 0.MG Added to the 07 //07 ALYACEN TAB / Added to the 07 //07 AMETHIA LO TAB Added to the 07 //07 ERGOT/CAFFEN TAB 00MG Added to the 07 //07 NORETH/ETHIN TAB /0 Added to the 07 //07 LORCET
3 Tier Formulary Additions
3 Tier Formulary Additions Drug Name Tier Category Management ACCU-CHECK GUIDE ME GLUCOSE METER 3 Diabetic Supplies Step Therapy applies pyridostigmine bromide 60mg/5ml syrup 1 Antimyasthenic Agents New
Quarterly Pharmacy Formulary Change Notice
MEDICAID PROVIDER BULLETIN February 26, 2015 Quarterly Pharmacy Formulary Change Notice Summary of Change: The formulary changes listed in the table below were reviewed and approved at our September 24,
Quarterly pharmacy formulary change notice
Quarterly pharmacy formulary change notice Provider update Summary: Effective August 1, 2018, the preferred formulary changes detailed in the table below will apply to District of Columbia Healthy Families
Drug Pipeline Update
CLINICAL SOLUTIONS Drug Insights > December 2015 Drug Pipeline Update New Drug Information Narcan (naloxone): Adapt Pharma and Lightlake Therapeutics received Food and Drug Administration (FDA) approval
January 2018 Pharmacy & Therapeutics Committee Decisions
UCare s Pharmacy and Therapeutics Committee (P&T) is a group of physicians and pharmacists that meet throughout the year to make changes to the UCare formulary (approved drug list). These changes are reviewed
ABILIFY INJ. Products Affected Step 2: ABILIFY MAINTENA PREFILLED SYRINGE 300 MG INTRAMUSCULAR ABILIFY MAINTENA PREFILLED SYRINGE 400 MG INTRAMUSCULAR
ABILIFY INJ ABILIFY MAINTENA PREFILLED SYRINGE 300 MG ABILIFY MAINTENA PREFILLED SYRINGE 400 MG ABILIFY MAINTENA SUSPENSION RECONSTITUTED ER 300 MG Claim will pay automatically for ABILIFY MAINTENA if
Quarterly pharmacy formulary change notice
The formulary changes listed in the table below apply to all Anthem HealthKeepers Plus and Anthem HealthKeepers Plus, Commonwealth Coordinated Care Plus (Anthem CCC Plus) members. These formulary changes,
PRECISION CANCER MEDICINE DR. VANESSA DICKEY TORRANCE MEMORIAL PHYSICIAN NETWORK CANCER CARE ASSOCIATES
PRECISION CANCER MEDICINE DR. VANESSA DICKEY TORRANCE MEMORIAL PHYSICIAN NETWORK CANCER CARE ASSOCIATES REAL PATIENT; ANN (ALIAS) 63 year old woman who smoked for 25 years, quit 15 years ago. Complained
Health Partners Medicare Special 2018 Formulary Changes
Health Partners Medicare Special 2018 Changes Changes occur, for example, because new drugs come on the market, a drug is moved to a different cost-sharing level (tier), or a generic version becomes available.
Beneficiary Advisory Panel Handout Uniform Formulary Decisions 23 June 2011
Beneficiary Advisory Panel Handout Uniform Formulary Decisions 23 June 211 PURPOSE: The purpose of this handout is to provide BAP Committee members with a reference document for the relative clinical effectiveness
Quarterly pharmacy formulary change notice
Quarterly pharmacy formulary change notice The formulary changes listed in the table below were reviewed and approved at our second quarter 2018 Pharmacy and Therapeutics Committee meeting. Effective October
2018 Medicare Part D Formulary Change
2018 Medicare Part D Formulary Change We may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, or add prior authorizations, quantity limits and/or step therapy
VIVA Health, Inc. Part D Cumulative Formulary Changes for 2009
ulary ulary Effective ADDS 00472088282 ACETASOL HC 2%; 1% SOLN Pref(1) no 1/29/2009 3/1/2009 68382026101 ACETAZOLAMIDE 500MG CP12 Pref(1) yes 3/24/2009 5/1/2009 00078056651 AFINITOR 5MG TABS Pref (4);
Quarterly pharmacy formulary change notice
Provider update Quarterly pharmacy formulary change notice Summary: The formulary changes listed in the table below were reviewed and approved at our first-quarter 2018, Pharmacy and Therapeutics Committee
June 2018 Pharmacy & Therapeutics Committee Decisions
UCare s Pharmacy and Therapeutics Committee (P&T) is a group of physicians and pharmacists that meet throughout the year to make changes to the UCare formulary (approved drug list). These changes are reviewed
Quarterly pharmacy formulary change notice
Provider Bulletin October 2018 Quarterly pharmacy formulary change notice The formulary changes listed in the table below apply to all Anthem HealthKeepers Plus patients. The changes listed in the table
2019 Drug List Negative Changes
2019 Drug List Negative Changes Updated 03/26/2019 If you are taking a drug that is removed from the formulary (also known as the Drug List), we will tell you. We will also tell you if we add any restrictions
Quarterly pharmacy formulary change notice
Provider Bulletin April 2018 This table is used by HealthKeepers, Inc. to indicate formulary changes applicable to all Anthem HealthKeepers Plus members. These changes were reviewed and approved at the
Quarterly pharmacy formulary change notice
MEDICAID PROVIDER BULLETIN March 2019 Quarterly pharmacy formulary change notice The formulary changes listed in the table below were reviewed and approved at the fourth quarter pharmacy and therapeutics
FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS
FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS DHMC/CHP+ may add or remove drugs from the formulary or make changes to restrictions on formulary drugs
NOTIFICATION OF FORMULARY CHANGES
NOTIFICATION OF CHANGES The following summary describes changes to the 2018 Presbyterian Senior Care (HMO)/(HMO-POS), Presbyterian MediCare PPO and formularies. The formulary may change at any time. You
2018 Formulary Update
MEDICARE ADVANTAGE BlueShield of Northeastern New York 2018 Formulary Update BlueShield of Northeastern New York has updated its formulary (drug list) since its original publication in January 2018. This
Alprazolam 0.25mg, 0.5mg, 1mg tablets
Presbyterian Senior Care (HMO) / Presbyterian MediCare PPO Quantity Limits Effective November 1, 2014 For the most recent list of drugs or other questions, please contact the Presbyterian Customer Service
Drug Formulary Update, January 2017 Commercial and State Programs
Drug Formulary Update, January 2017 Commercial and State Programs Updates to the HealthPartners Commercial and State Program Drug Formularies are listed below. Updates apply to all Commercial groups (PreferredRx,
FORMULARY CHANGE NOTICE 2008 JULY
FORMULARY CHANGE NOTICE 2008 JULY Drug Name Dosage Form Strength Alternative Medicine* Formulary Formulary Change and Reason Status of Alternative Medication Updated Status On Formulary STARLIX TABS 120MG
LIST OF DRUGS THAT MAY BE COVERED UNDER YOUR MEDICAL BENEFIT
LIST OF DRUGS THAT MAY BE COVERED UNDER YOUR MEDICAL BENEFIT The following medications may be covered under your medical benefit if they are provided to you in your doctor s office or outpatient infusion
2019 Formulary Update
MEDICARE ADVANTAGE BlueShield of Northeastern New York Formulary Update BlueShield of Northeastern New York has updated its formulary (drug list) since its original publication in January. This document
Quarterly pharmacy formulary change notice
MEDICAID PROVIDER BULLETIN October 2018 The formulary changes listed in the table below were reviewed and approved at the second-quarter 2018 Pharmacy and Therapeutics Committee meeting. Effective October
FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS
FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS DHMC/CHP+ may add or remove drugs from the formulary or make changes to restrictions on formulary drugs
CRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication.
ADHD STIMULANTS ATOMOXETINE HCL, DEXEDRINE 10 MG TABLET, DEXEDRINE 5 MG TABLET, DEXMETHYLPHENIDATE HCL, DEXMETHYLPHENIDATE HCL ER, DEXTROAMPHETAMINE 10 MG TAB, DEXTROAMPHETAMINE 5 MG TAB, DEXTROAMPHETAMINE
WellCare Signature (PDP) and WellCare Classic (PDP) Formulary Addendum
WellCare Signature (PDP) and WellCare Classic (PDP) Formulary Addendum This is a listing of the changes that have occurred in our formulary. Please carefully review these changes and call WellCare if you
Pharmacy and Therapeutics (P&T) Committee Provider Update
Pharmacy and Therapeutics (P&T) Committee Provider Update FIRST QUARTER 2017 P&T Committee Decisions effective March 1, 2017 Dear Healthcare Practitioner: The Presbyterian Health Plan, Inc., and Presbyterian
Quarterly pharmacy formulary change
Medi-Cal Managed Care L. A. Care Major Risk Medical Insurance Program Provider Bulletin The formulary changes listed in the table below were reviewed and approved at our first-quarter 2018 Pharmacy and
ANTICONVULSANT THERAPY
Network Health Insurance Corporation NetworkCares Step Therapy Last Updated: 7/2017 ANTICONVULSANT THERAPY Aptiom 200 mg tablet Aptiom 400 mg tablet Aptiom 600 mg tablet Aptiom 800 mg tablet Banzel 200
2017 Formulary Changes Year to Date
2017 Formulary Changes Year to Date Health Choice Arizona may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, add prior authorization, quantity limits and/or
Drug Name Description of Change Formulary Coverage Formulary Alternative(s)
NOTIFICATION OF FORMULARY CHANGES The following summary describes changes to the Presbyterian Centennial Care Formulary effective 2018. For the most recent list of drugs, information on asking for a prior
Presbyterian Health Plan, Inc. Presbyterian Insurance Company, Inc. NOTIFICATION OF FORMULARY CHANGES
NOTIFICATION OF FORMULARY CHANGES The following summary describes changes to the Presbyterian Commercial Large Group Plans (Non-Metal Plans) Formularies effective 2018. For the most recent list of drugs,
PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES
PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Generic Additions These generic drugs recently became available in the marketplace. When these generic drugs became available, we began covering them at the
Step Therapy Requirements. Effective: 1/1/2019
Effective: 1/1/2019 Updated 1/2019 AMANTADINE ER Sharp Health Plan (HMO) OSMOLEX ER 129 MG, EXTENDED RELEASE OSMOLEX ER 193 MG, EXTENDED RELEASE OSMOLEX ER 258 MG, EXTENDED RELEASE PRIOR CLAIM FOR AMANTADINE
Oregon Health Plan prescription benefit updates
Oregon Health Plan prescription benefit updates EOCCO s prescription program is a pharmacy benefit that offers members a choice of safe and effective medication treatments. The program also helps you save